icosmatrix
Small moleculeexperimental
Clinical trial activity
4 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2005 (NCT00199901)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- icosmatrix
- iscomatrix
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01477580 | Phase 1 | Jul 1, 2012 | Merck |
| NCT01341496 | Phase 1 | Apr 18, 2011 | National Cancer Institute (NCI) |
| NCT00464334 | Phase 1 | Mar 1, 2007 | Merck |
| NCT00199901 | Phase 2 | Sep 1, 2005 | Ludwig Institute for Cancer Research, Royal Marsden Hospital NHS Trust, University of London |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 2 | 2 | 1 | 2007 |
| Ludwig Institute for Cancer Research | Academic/Hospital | 1 | 1 | 1 | 2005 |
| National Cancer Institute (NCI) | Government | 1 | 1 | 1 | 2011 |
| Royal Marsden Hospital NHS Trust | Academic/Hospital | 1 | 0 | 1 | 2005 |
| University of London | Academic/Hospital | 1 | 0 | 1 | 2005 |
5 organizations
Page 1 / 1